Toragen Competitors and Similar CompaniesClear all
Xencor's competitors and similar companies include Bio-Path Holdings.
 Xencor Xencor is a clinical-stage biopharmaceutical company which focuses on discovery and development of engineered monoclonal antibodies to treat severe and life-threatening diseases with unmet medical needs. |  Bio-Path Holdings Bio-Path Holdings is a clinical and preclinical stage oncology focused antisense drug development company. | |
Founding Date | Founding Date 1997 | Founding Date 2007 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Pasadena, US HQ San Diego, US | Locations Bellaire, US HQ |
Employees | Employees 2604% increase | Employees 913% increase |
Valuation ($) | Valuation ($) 1.5 b | Valuation ($) 4 m |
Financial | ||
Net income | Net income ($92.1m) (FY, 2025) | Net income ($9.9m) (FY, 2024) |
Funding | ||
Total funding raised | Total funding raised $ 108.4m | Total funding raised $ 2.3m |
For sources of this data, please see the company profile
View Company Profiles
Bio-Path Holdings
HQ
Bellaire, US
Employees
9↑ 13% increase
Bio-Path Holdings is a clinical and preclinical stage oncology focused antisense drug development company.
View company